Less Ads, More Data, More Tools Register for FREE

Transaction in Own Shares

16 Sep 2024 17:30

RNS Number : 3991E
IMI PLC
16 September 2024
Β 

16 September 2024

IMI plc ("IMI" or the "Company")

Transaction in Own Shares

LEI: 2138002W9Q21PF751R30

IMI announces that on 16 September 2024 it purchased through Merrill Lynch International the following number of its ordinary shares for cancellation at an average price of 1,827.1019 pence per share:

Date of purchase:

16 September 2024

Number of ordinary shares purchased:

99,565

Highest purchase price paid per share:

1,830.00p

Lowest purchase price paid per share:

1,816.00p

Volume weighted average price paid per share:

1,827.10p

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 272,703,440. The Company holds 13,648,836 ordinary shares in treasury and therefore the total number of voting rights in the Company will be 259,054,604.

Aggregated Information

Β 

Date

Trading venue

Volume weighted average price (Β£ per share)

Number of Shares Purchased

16 September 2024

London Stock Exchange

18.27

77,600

16 September 2024

Chi-X (CXE)

18.26

16,028

16 September 2024

BATS (BXE)

18.25

3,438

16 September 2024

Turquoise

18.26

2,499

Transaction Details

Β 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Merrill Lynch International on behalf of the Company as part of the Programme is detailed on the attached:

http://www.rns-pdf.londonstockexchange.com/rns/3991E_1-2024-9-16.pdf

Enquiries:

IMI plc

Louise Waldek, Company Secretary

0121 717 3700

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSQKABBABKDCCD

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS